- Description
- Benefits
- Risks
- Additional information
- Research
Description
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), studied in laboratory environments for its role in growth hormone (GH) secretion, endocrine signalling, and metabolic pathway research.
It is designed to stimulate the pituitary gland via GHRH receptor activation, promoting controlled growth hormone release within experimental models. Due to its structure and activity profile, Tesamorelin is widely investigated in studies focusing on the GH/IGF-1 axis, metabolic regulation, and hormone-driven signalling systems.
In controlled research settings, Tesamorelin is explored for its influence on lipid metabolism, cellular signalling, and endocrine system regulation, making it a key compound in research involving metabolic processes and hormonal pathways.
Across Ireland and Europe, Tesamorelin is commonly studied in areas such as:
- Growth hormone secretion and GHRH receptor activation
- GH/IGF-1 axis and endocrine signalling
- Metabolic regulation and lipid metabolism research
- Hormone-driven cellular signalling pathways
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – Tesamorelin
| Specification | Details |
|---|---|
| Product Name | Tesamorelin |
| Compound Type | Synthetic GHRH analogue peptide |
| Functional Class | Growth hormone-releasing hormone analogue |
| Mechanism of Action | Activates GHRH receptors to stimulate GH release |
| Biological Targets | Pituitary gland, GH/IGF-1 axis |
| Structure | Modified GHRH analogue |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
Researched Benefits & Focus Areas – Tesamorelin
1. Growth Hormone (GH) Secretion Research
Tesamorelin has been studied for:
- Stimulation of endogenous GH release via GHRH receptors
- Investigation of pituitary gland signalling pathways
- Analysis of controlled hormone secretion mechanisms
Reference basis: Derived from endocrinology research examining GHRH analogues and GH release dynamics.
2. GH/IGF-1 Axis & Endocrine Signalling
Research has explored:
- Interaction with the GH/IGF-1 signalling pathway
- Regulation of hormone-driven cellular processes
- Influence on endocrine system communication
Reference basis: Based on studies investigating GH axis regulation and endocrine signalling mechanisms.
3. Metabolic & Lipid Regulation Research
Tesamorelin is commonly studied for:
- Influence on lipid metabolism pathways
- Investigation of metabolic regulation systems
- Interaction with energy utilisation and storage mechanisms
Reference basis: Supported by research into GHRH analogues and metabolic signalling pathways.
4. Hormonal Pathway Modulation
- Studied for its role in hormone-driven cellular signalling
- Explored in endocrine system regulation models
- Investigated for interaction with metabolic and growth pathways
Reference basis: Derived from research into peptide-mediated endocrine modulation.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – Tesamorelin
1. Hormonal System Influence
- May significantly affect growth hormone levels
- Potential for endocrine imbalance in research models
Reference basis: Based on studies examining GH regulation and hormonal feedback systems.
2. Metabolic Pathway Effects
- May influence lipid and glucose metabolism
- Potential for system-wide metabolic changes
Reference basis: Derived from research into metabolic signalling and endocrine interactions.
3. Endocrine Feedback Mechanisms
- May impact natural hormonal feedback loops
- Potential for overstimulation or suppression of pathways
Reference basis: Based on studies examining GH/IGF-1 axis feedback systems.
4. Limited Long-Term Research
- Lack of extensive long-term data
- Primarily studied in controlled laboratory environments
Reference basis: Reflects the current stage of Tesamorelin research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS